.svg)
Collinsella aerofaciens: A Single-Species Window Into Carb and Bile Acid Handling
A Collinsella aerofaciens test analyzes a stool sample to quantify the relative abundance of Collinsella aerofaciens, a common gut bacterium within the Actinobacteria group. Labs measure its DNA using modern sequencing methods such as 16S rRNA profiling or shotgun metagenomics to estimate how much Collinsella is present compared with other microbes. Results are typically reported as a percentage of total microbial reads and may be benchmarked against a reference cohort to show whether your level is lower, average, or higher than peers. Because the gut ecosystem is dynamic, results reflect your current state rather than a fixed trait.
Why Collinsella matters: this microbe ferments carbohydrates to produce short-chain metabolites, interacts with bile acids, and has been associated in research with lipid and glucose patterns, intestinal permeability, and inflammation signals. In practical terms, Collinsella can rise with highly processed, low-fiber eating and fall with fiber-forward patterns, though there is wide individual variation. Higher Collinsella has been linked in several cohorts to higher triglycerides and insulin resistance tendencies, while lower levels often appear in more plant-diverse diets, though causality is not proven and more research is needed. Your number does not diagnose disease; it adds context to how your gut community supports or strains digestion and metabolic balance.
Why This Microbe Earns a Closer Look
Collinsella aerofaciens sits at the intersection of digestion and metabolism. It helps break down carbohydrates and interacts with bile acids that carry cholesterol and fats through the gut. In cell and human cohort studies, higher Collinsella has been associated with increased gut permeability and pro-inflammatory signaling, as well as higher triglycerides and LDL cholesterol in some populations, while lower levels often track with more fiber-rich patterns. Think of it like a dial: if Collinsella is turned up in a low-fiber, high-refined-carb routine, you may see more gas after meals and metabolic labs drifting upward; if it is dialed down in a diverse, plant-forward pattern, you may see steadier stools and a friendlier lipid profile — individual responses vary.
Testing becomes especially helpful when you want to connect everyday choices with measurable biology. After antibiotics or frequent acid-reducer use, Collinsella may shift, changing how you process carbs and bile acids. Major diet changes, travel, or a new GLP-1 regimen can alter motility and meal patterning, which can ripple through Collinsella levels and fermentation activity. If you are tracking persistent bloating, fluctuating stools, or upward trends in triglycerides, measuring Collinsella alongside other microbiome and blood markers can clarify whether your gut ecosystem is amplifying or buffering those signals. The goal is not to chase a single “perfect” value; it is to observe patterns that align with symptoms and labs so you and your clinician can make informed, targeted adjustments.
Reading the Result in Context
Your report will show Collinsella as a relative abundance compared with a reference population. In diverse, resilient microbiomes, Collinsella is typically present at low to moderate levels. There is no universal “optimal,” but mid-range values within a balanced community often suggest steady carbohydrate fermentation, routine bile acid transformation, and a calmer inflammatory tone.
Higher-than-average Collinsella may reflect a gut environment that favors fast carbohydrate fermentation, which can coincide with gas, post-meal bloating, or looser stools. Observational studies have linked higher Collinsella to less favorable lipid and glucose patterns, though associations are not destiny and must be interpreted in context. Lower-than-average Collinsella can be entirely normal, particularly in fiber-rich, plant-diverse diets where other beneficial fermenters are abundant; very low levels, on their own, do not signal a problem.
Pairing Collinsella With the Bigger Picture
Interpretation is strongest when you connect this single microbe to the larger picture. Pair Collinsella with total microbiome diversity, beneficial genera (for example, Bifidobacterium and Faecalibacterium), and blood markers such as triglycerides, LDL-C, fasting glucose, and A1c. Repeating the test can show whether your gut community is trending toward stability as your habits evolve.
What a Collinsella aerofaciens Reading Actually Buys You
Important caveats: stool results are a snapshot and can vary day to day; methods differ across labs, and 16S versus metagenomics can yield slightly different estimates. Recent antibiotics, colonoscopy prep, laxatives, or acute illness can shift readings. Use this result as a conversation starter with your clinician to align symptoms, diet, medications, and labs into a coherent plan.
FAQs
The Collinsella aerofaciens Test analyzes the genetic material (DNA/RNA) of bacteria, fungi and other microorganisms in a stool sample to identify which species are present, their relative abundance, and their functional potential (for example genes and pathways that suggest metabolic capabilities). It reports the presence and quantity of Collinsella aerofaciens within the broader microbial community and characterizes species diversity and composition.
These results describe microbial balance, diversity and potential function in the gut—they indicate the microbiome profile, not the presence or absence of a specific disease. Test findings are not diagnostic on their own and should be interpreted alongside clinical information and other medical tests if health concerns exist.
The Collinsella aerofaciens test is a simple at‑home stool collection: the kit includes a small swab or a tiny vial for collecting a small amount of stool, which you use to transfer the sample into the provided container and seal per the kit instructions.
Maintain good hygiene during collection, clearly label the sample with the required information, and follow the kit’s instructions exactly (including sealing, storage, and return/shipping steps) to avoid contamination and ensure accurate sequencing results.
A Collinsella aerofaciens test can provide clues about gut function: its abundance and activity may give insights into digestion (carbohydrate fermentation and gas production), intestinal inflammation, nutrient absorption (including effects on bile acids and certain vitamins), aspects of metabolism (potential links to lipid and glucose handling), and gut–brain communication (through influences on immune signaling and metabolites that affect neurotransmitter pathways).
These microbiome patterns can correlate with—but do not diagnose—specific diseases or conditions; results are best interpreted alongside symptoms, clinical tests, and professional medical advice rather than used alone as a definitive diagnosis.
Next‑generation sequencing (NGS)–based assays provide high‑resolution microbial data and can often detect Collinsella aerofaciens at or near the species level, but interpretation of Collinsella aerofaciens test results is probabilistic rather than definitive: these tests detect microbial DNA/RNA and relative abundance, which indicate presence and quantity trends but do not prove viability or direct causation.
Results reflect a snapshot in time and can change — they may vary with recent diet, physiological stress, or recent antibiotic use — so clinical context and, if needed, repeat sampling should inform any decisions based on the test.
Many people test their collinsella aerofaciens once per year to establish a baseline, or every 3–6 months if they are actively adjusting diet, taking probiotics, or trying other interventions to see how those changes affect levels.
Emphasize comparing trends across repeat tests rather than relying on a single reading—serial measurements reveal direction and consistency of change and are far more useful for guiding decisions than one-off results.
Yes — microbial populations, including those of Collinsella aerofaciens, can shift within days in response to dietary or lifestyle changes (for example, changes in fiber intake, antibiotics, travel or sleep patterns). However, while short-term fluctuations are common, more stable community patterns typically emerge over weeks to months rather than hours or days.
For meaningful comparisons, aim to keep diet, medications and other lifestyle factors consistent for several weeks before retesting, because testing too soon may reflect transient changes rather than a true long‑term shift.
References
- Astbury, S., Atallah, E., Vijay, A., Aithal, G. P., Grove, J. I., & Valdes, A. M. (2020). Lower gut microbiome diversity and higher abundance of proinflammatory genus Collinsella are associated with biopsy-proven nonalcoholic steatohepatitis. Gut Microbes, 11(3), 569-580. https://doi.org/10.1080/19490976.2019.1681861
- Koh, A., De Vadder, F., Kovatcheva-Datchary, P., & Bäckhed, F. (2016). From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites. Cell, 165(6), 1332-1345. https://doi.org/10.1016/j.cell.2016.05.041
- Durazzi, F., Sala, C., Castellani, G., Manfreda, G., Remondini, D., & De Cesare, A. (2021). Comparison between 16S rRNA and shotgun sequencing data for the taxonomic characterization of the gut microbiota. Scientific Reports, 11, 3030. https://doi.org/10.1038/s41598-021-82726-y
- Lynch, S. V., & Pedersen, O. (2016). The human intestinal microbiome in health and disease. The New England Journal of Medicine, 375(24), 2369-2379. https://doi.org/10.1056/NEJMra1600266
- Porcari, S., Mullish, B. H., Asnicar, F., Ng, S. C., Zhao, L., Hansen, R., O'Toole, P. W., Raes, J., Hold, G., Putignani, L., Gasbarrini, A., Segata, N., & Cammarota, G. (2025). International consensus statement on microbiome testing in clinical practice. The Lancet Gastroenterology & Hepatology, 10(2), 154-167. https://doi.org/10.1016/S2468-1253(24)00311-X
.avif)
.svg)
.svg)
